Founded in the field of diagnosis in June 2003, Seebio Biotech (Shanghai) Co., Ltd., is the priority service company in the field of life science with rapid developments. Seebio has received approval from the National Equities Exchange and Quotations ("NEEQ") in China to list its shares on the New Third Board, the over-the-counter (OTC) stock exchange in China in July 28, 2016. Stock code: 837709.
Seebio provides not only the proprietary Seebio and Canmedo products but also more than 1,000,000 kinds of imported products, and offers overseas purchasing and ordering services. These products and services have been nationwide accepted by universities, institutes, hospitals and related biotechnological or chemical companies. We have won customers’ recognition and trust by high quality and expert technical services for the past twelve years’ development and dedication.
Our current products include analytical reagents, biochemical reagents, catalysts, lab wares and consumables, which are extensively applied in four major fields, namely, life science, health care, material science and equipment technology. In addition, we provide out-services for CRO enterprises that are the important project in recent years, such as, Glycosylation and detection of drugs, mPEG modification and denaturation of proteins and compounds, modification and denaturation and solubilization of unstable or non-soluble compounds, R&D of diagnostic kits and so on.
Our members are mainly composed of young innovative and aspiring people (15% with master’s degree and above, 70% with bachelor’s degree and above).
Seebio adheres to customers’ needs, satisfies customers by taking the market as guidance and clients as the core, and seeks excellence and continuous improvement by regarding customer satisfaction as our pursuit.
With the introduction of information management & network sales system, we are trying to improve management and operation, enhance operational efficiency and reduce cost.
Our mission is to create complete product lines, improve supply chain, expand business scope and become a human-oriented, diversified, international high-tech industrial group. Our ambition is to become a leading Chinese-preferred service company in the field of life science.